Understand the source comparison
GW-501516 vs Peptides: Key Differences
Mechanism PPARδ agonist Hormone-mimicking / receptor binding Regulatory Status Banned/unapproved Some approved medically, many off-label Research Base Animal studies with safety concerns Clinical use in certain conditions Administration Oral Subcutaneous or in
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Mechanism
- PPARδ agonist
- Hormone-mimicking / receptor binding
- Regulatory Status
- Banned/unapproved
- Some approved medically, many off-label
- Research Base
- Animal studies with safety concerns
- Clinical use in certain conditions
- Administration
- Oral
- Subcutaneous or intramuscular injection
- Main Appeal
- Endurance, fat loss
- Muscle growth, repair, anti-aging
- Known Major Risks
- Cancer risk (animals), organ stress
- Injection risks, hormonal imbalance